Richard Fumitsugu Arakaki MD
Diabetes, Lipid Metabolism
Professor, Medicine, University of Hawaii John A Burns School of Medicine
Join to View Full Profile
1356 Lusitana StFl 7Honolulu, HI 96813
Dr. Arakaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineResidency, Internal Medicine, 1982 - 1985
University of Hawaii, John A. Burns School of MedicineClass of 1982
Certifications & Licensure
HI State Medical License 1990 - 2026
CA State Medical License 2021 - 2025
MD State Medical License 1985 - 1990
TX State Medical License 1983 - 1985
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
- A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsSodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes.Richard Arakaki
Postgraduate Medicine. 2016-04-04 - 18 citationsPsychosocial and Clinical Outcomes of a Cognitive Behavioral Therapy for Asians and Pacific Islanders with Type 2 Diabetes: A Randomized Clinical Trial.Jillian Inouye, Dongmei Li, James Davis, Richard Arakaki
Hawai'i Journal of Medicine & Public Health. 2015-11-01 - 1 citationsTreatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort.Kieren J. Mather, Qing Pan, William C. Knowler, Tohru Funahashi, George A. Bray
Plos One. 2015-08-27
Grant Support
- In Vitro Translation Study Of Human Insulin Receptor Fatty AcylationNational Institute Of General Medical Sciences1998–2001
- In Vitro Translation Study Of Human Insulin Receptor Fatty AcylationNational Institute Of General Medical Sciences1996–1997
- Insulin Sensitivity In Native Hawaiians With NIDDMNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
